Stem-cell screening projects can fail at the interpretation stage when selective binding, differentiation, proliferation, and tissue regeneration are treated as if they were the same outcome. A peptide may preferentially bind an undifferentiated or lineage-committed population without changing cell fate, while a candidate that increases cell number may shift bulk marker levels without inducing differentiation. Creative Biolabs designs Functional Phage Display Screening programs so these possibilities are separated from the beginning.

We can support discovery of cell-state-selective ligands, candidates that modulate a defined differentiation trajectory, or target hypotheses associated with a transition between states. Positive and negative cell populations are chosen according to the biological question—undifferentiated versus differentiated, one lineage versus another, target-positive versus target-negative, or another matched comparison. After enrichment, candidate behavior is tested with a lineage-appropriate marker panel, proliferation and viability controls, and, where informative, morphology or functional assays.

For programs connected to biomaterials or tissue-engineering research, we also consider how matrix coating, substrate stiffness, ligand immobilization, density, orientation, and culture timing can alter both cell binding and phenotype. In vitro differentiation results are kept distinct from later tissue, organoid, homing, or in vivo evidence. This gives you a practical path from discovery to the level of biological confirmation your research actually requires.